Anika Therapeutics (ANIK)
(Delayed Data from NSDQ)
$25.57 USD
-0.01 (-0.04%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $25.50 -0.07 (-0.27%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth D Momentum B VGM
Earnings News For ANIK
-
Anika: Q4 Earnings Snapshot
-
Anika Reports Fourth Quarter and Year-End 2023 Financial Results
-
Anika: Q3 Earnings Snapshot
-
Anika Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance on Growing Momentum Across the Business
-
Anika Therapeutics (ANIK) Reports Q2 Loss, Tops Revenue Estimates
-
Anika: Q2 Earnings Snapshot
-
Anika Reports Second Quarter 2023 Financial Results
-
Anika Therapeutics (ANIK) Reports Q1 Loss, Tops Revenue Estimates
-
Anika: Q1 Earnings Snapshot
-
Anika Reports First Quarter 2023 Financial Results
-
Anika Therapeutics (ANIK) Reports Q4 Loss, Tops Revenue Estimates
-
Anika: Q4 Earnings Snapshot
-
Anika Reports Fourth Quarter and Year-End Fiscal 2022 Financial Results
-
Anika (ANIK) to Report Q4 Earnings: What's in the Cards?
-
Anika Therapeutics (ANIK) Reports Q3 Loss, Tops Revenue Estimates
-
Anika: Q3 Earnings Snapshot
-
Anika Reports Third Quarter Fiscal 2022 Financial Results
-
Anika Therapeutics (ANIK) Reports Q2 Loss, Tops Revenue Estimates
-
Anika Therapeutics (ANIK) Tops Q3 Earnings and Revenue Estimates
-
Anika Therapeutics (ANIK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
-
Earnings Preview: Anika Therapeutics (ANIK) Q2 Earnings Expected to Decline
-
Anika Therapeutics (ANIK) Surpasses Q1 Earnings and Revenue Estimates
-
Anika Therapeutics (ANIK) Reports Q4 Loss, Lags Revenue Estimates
-
Anika Therapeutics (ANIK) Reports Q3 Loss, Lags Revenue Estimates
-
Analysts Estimate Anika Therapeutics (ANIK) to Report a Decline in Earnings: What to Look Out for